Coronavirus Update: CoVIg-19 Alliance Ends As Trial Misses Endpoints

Plus: India Production Deals For RDIF

immunoglobulin
Trial Outcome Dashes Hopes For Alliance's Hyperimmune Immunoglobulin • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip